» Articles » PMID: 20932736

Health-related Quality of Life in Patients by COPD Severity Within Primary Care in Europe

Overview
Journal Respir Med
Publisher Elsevier
Specialty Pulmonary Medicine
Date 2010 Oct 12
PMID 20932736
Citations 93
Authors
Affiliations
Soon will be listed here.
Abstract

Pan-European data on health-related quality of life (HRQL) in chronic obstructive pulmonary disease (COPD) are lacking. This cross-sectional epidemiological study evaluated health status in 1817 COPD patients from an 'all-comers' primary care population in seven European countries (87% stable disease; 13% with current exacerbation) using: St George's Respiratory Questionnaire-COPD specific (SGRQ-C), the short form health survey (SF-12) and the Functional Assessment of Chronic Illness Therapy (FACIT) Fatigue scale. Mean total score for SGRQ was 44.7 ± 19.4 showing marked impairment of HRQL. Scores differed little between countries (range 39.2-50.1). Impairment was associated with the severity of airway obstruction, but within each GOLD stage the variation (SD) was wide [Stage I: 38.5 ± 19.3 (n = 223); Stage II: 40.4 ± 18.1 (n = 868); Stage III: 50.2 ± 18.6 (n = 551); Stage IV: 58.6 ± 17.7 (n = 144)]. Patients suffering an exacerbation had a worse SGRQ score (54.9 ± 19.3) than those with stable disease (43.3 ± 19.0). The presence of ≥3 co-morbidities (CM) was also associated with a significantly worse score (49.9 ± 19.1) vs. 1-2 CM (42.1 ± 19.1) or no CM (42.3 ± 18.6). Findings with the SF-12 and FACIT-F results were consistent with those from the SGRQ-C. This large observational primary care study shows that health status is significantly impaired in COPD patients of all severities, even in those with mild airway obstruction. Within each GOLD stage of severity there is considerable heterogeneity in HRQL impairment among patients. (Study number: 111749).

Citing Articles

Remote monitoring of patients with COPD disease using a tablet system: a randomised crossover study of quality-of-life measurements.

Frerichs M, Li H, Andersson A, Andelid K, Crona M, Vanfleteren L ERJ Open Res. 2025; 11(1.

PMID: 39811558 PMC: 11726541. DOI: 10.1183/23120541.00532-2024.


Research Status and Direction of Chronic Obstructive Pulmonary Disease Complicated with Coronary Heart Disease: A Bibliometric Analysis from 2005 to 2024.

Bian H, Zhu S, Xing W, Qi L, Xue J, Peng X Int J Chron Obstruct Pulmon Dis. 2025; 20():23-41.

PMID: 39802036 PMC: 11724669. DOI: 10.2147/COPD.S495326.


Mobile App for Patients With Chronic Obstructive Pulmonary Diseases During Home-Based Exercise Care: Usability Study.

Chien S JMIR Hum Factors. 2024; 11:e60049.

PMID: 39546767 PMC: 11607552. DOI: 10.2196/60049.


Periodontal disease: A systemic condition.

Villoria G, Fischer R, Tinoco E, Meyle J, Loos B Periodontol 2000. 2024; 96(1):7-19.

PMID: 39494478 PMC: 11579822. DOI: 10.1111/prd.12616.


An Italian Delphi Consensus on the Triple inhalation Therapy in Chronic Obstructive Pulmonary Disease.

Solidoro P, Dente F, Micheletto C, Pappagallo G, Pelaia G, Papi A Multidiscip Respir Med. 2024; 19.

PMID: 39291458 PMC: 11414512. DOI: 10.5826/mrm.2024.949.